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Summary
 
The velocity of rolling leukocytes is thought to be determined by the expression of adhesion
molecules and the prevailing wall shear stress. Here, we investigate whether rapid cleavage of
L-selectin may be an additional physiologic regulatory parameter of leukocyte rolling. A
unique protease in the membrane of leukocytes cleaves L-selectin after activation, resulting in
L-selectin shedding. The hydroxamic acid–based metalloprotease inhibitor KD-IX-73-4 com-
pletely prevented L-selectin shedding in vitro and significantly decreased the rolling velocity of
leukocytes in untreated wild-type C57BL/6 mice from 55 to 35 
 
m
 
m/s in vivo. When E-selectin
was expressed on the endothelium (tumor necrosis factor [TNF]-
 
a 
 
treatment 2.5–3 h before
the experiment), rolling velocity was 4 
 
m
 
m/s and did not change after the application of KD-IX-
73-4. However, KD-IX-73-4 decreased mean rolling velocity by 29% from 23 to 16 
 
m
 
m/s in
E-selectin–deficient mice treated with TNF-
 
a
 
. The reduction of velocity caused by KD-IX-
73-4 was immediate (
 
,
 
5 s) after injection of KD-IX-73-4 as shown by a novel method using a
local catheter. These results establish a role for L-selectin shedding in regulating leukocyte roll-
ing velocity in vivo.
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eukocyte rolling is the initial step in the recruitment of
leukocytes to the site of acute inflammation (1, 2). L-,
E-, and P-selectin are transmembrane glycoproteins known
to mediate leukocyte rolling on microvascular endothelial
cells (3–5). L-selectin (CD62L), a molecule expressed ex-
clusively on the surface of leukocytes, interacts with a yet
unidentified ligand on venular endothelial cells and partici-
pates in mediating leukocyte rolling under physiologic
conditions (5, 6). It has been hypothesized that leukocyte
rolling is accomplished by rapid formation and subsequent
release of bonds between selectins and their ligand(s) (7, 8).
A high rate of bond detachment of L-selectin under tension
has been predicted (8) and is supported by experimental
evidence (9, 10). The present study is designed to explore
whether rapid cleavage of bound L-selectin may be respon-
sible for releasing the trailing end of rolling leukocytes from
the endothelial surface during rolling.
L-selectin is rapidly shed from the surface of the leuko-
cytes upon their activation (11, 12). Stimuli inducing en-
doproteolytic release of L-selectin include chemokines like
IL-8 and other chemoattractants (
 
N
 
-formylmethionyl leu-
cylphenylalanine, platelet activating factor [12]). L-selectin
shedding may also be one of the relevant factors in the re-
cruitment of polymorphonuclear granulocytes (PMNs)
 
1
 
from the bone marrow, since a reduction of L-selectin ex-
pression on polymorphonuclear leukocytes has been re-
ported after their release from bone marrow (13).
L-selectin is cleaved at a membrane-proximal site be-
tween Lys
 
321
 
 and Ser
 
322
 
 in a region that links the second
short consensus repeat (SCR) and the transmembrane do-
main (14). The protease releases a large soluble extracellular
fragment (sL-selectin) of 68 kD and a 6-kD transmembrane
peptide fragment (15). Soluble L-selectin is functionally ac-
tive, and can inhibit leukocyte attachment to the endo-
thelium (16). Although other cell markers (CD14, CD16,
CD43, CD44, and CD50) also show a downregulation
upon activation, the shedding of L-selectin is distinct, be-
cause it is unusually rapid and resistant to common protease
inhibitors (12, 17–19), including the tissue inhibitor of
metalloproteinases (TIMP [20]). An unidentified metallo-
protease is believed to be responsible for the shedding of
L-selectin (20). The activity of this metalloprotease can be
 
1
 
Abbreviations used in this paper:
 
 HUVEC, human umbilical vein endothe-
lial cell; PMN, polymorphonuclear granulocyte; SI, slower isomer (nega-
tive control). 
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effectively inhibited by a hydroxamic acid–based metallo-
protease, KD-IX-73-4 (21). A similar hydroxamate-based
metalloprotease inhibitor, N-(
 
d
 
,
 
l
 
-[2-(hydroxyaminocarbo-
nyl)-methyl]-4-methylpentano)-
 
l
 
-3-(tert-butyl)-alanyl-
 
l
 
-alanine, 2-aminoethyl amide, blocks the release of TNF,
TNF receptors (CD120a and CD120b), IL-6 receptor, and
L-selectin release from leukocytes (22). The hydroxamic
acid–based inhibitor of zinc-dependent matrix metallopro-
teinases, Ro 31-9790, has also been shown to inhibit L-selec-
tin shedding from leukocytes (20).
Previous in vitro studies have shown that incubation of
neutrophils with KD-IX-73-4 alters their rolling and
causes increased neutrophil accumulation on immobilized
MECA-79 antigen coated on the lower wall of a flow
chamber (23). However, later in vitro results from Allport
et al. with human neutrophils on activated human umbili-
cal vein endothelial cells (HUVECs) did not show any reg-
ulatory function for L-selectin shedding in terms of neutro-
phil attachment, rolling, or transmigration (24). Motivated
by the controversial role of L-selectin shedding, and the
lack of any plausible explanation for the abundance of solu-
ble L-selectin in vivo, we hypothesized a role for L-selectin
shedding in the mechanism of physiologic leukocyte rolling.
To determine whether and to what extent L-selectin
shedding affects leukocyte rolling, we designed intravital
microscopic observations of rolling leukocytes before and
after inhibition of L-selectin shedding. We also developed a
new method for local application of compounds directly
into the microcirculation of mouse cremaster muscle, which
allows observations of rolling leukocytes during or briefly
after their contact with the protease inhibitor KD-IX-73-4
or appropriate control peptide. We used this method to
assess the contribution of rapid L-selectin cleavage to phys-
iologic leukocyte rolling.
 
Materials and Methods
 
Protease Inhibitor. 
 
KD-IX-73-4 (HO-NH-CO-CH
 
2
 
-CH(CH
 
2
 
-
CH(CH
 
3
 
)
 
2
 
)-CO-Nal-Ala-NH
 
2
 
) was a gift from Dr. T.K. Kishi-
moto (Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield,
CT). 0.5 mg of the protease inhibitor KD-IX-73-4 was solubilized
in 50 
 
m
 
l DMSO and diluted with saline to a final concentration of
1 mg/ml. 150 
 
m
 
g of KD-IX-73-4 was used in in vivo experiments
for an estimated initial serum concentration of 50 
 
m
 
g/ml.
A related hydroxamic acid–based compound (slower isomer
[SI]) HO-NH-CO-CH
 
2
 
-CH(CH
 
2
 
-CH(CH
 
3
 
)
 
2
 
)-CO-Nal-Ala-
NH-CH
 
2
 
-CH
 
2
 
-NH
 
2
 
 was obtained from Peptides International.
SI was solubilized, diluted, and aliquoted as described for KD-IX-
73-4. SI was used in the experiments as a negative control. SI did
not show any inhibitory effect on downregulation of L-selectin from
neutrophils after activation with PMA (100 ng/ml; flow cytometry).
 
mAbs. 
 
mAb RB40.34 (rat IgG1, 30 
 
m
 
g/mouse) is a blocking
mAb against murine P-selectin and was purified from hybridoma
supernatant (25). mAb 9A9 (rat IgG1, 30 
 
m
 
g/mouse) is a block-
ing mAb against murine E-selectin (26, 27). TNF-
 
a 
 
(0.5 
 
m
 
g/
mouse) was obtained from Genzyme Corp.
 
Animals.
 
Experiments were performed on a total of 30 male
mice 8–10 wk old and weighing 22–26 g. Mice included wild-
type C57BL/6 (Hilltop), gene-targeted mice deficient in L-selec-
tin (28), and gene-targeted mice deficient in E-selectin (29).
Both L- and E-selectin knockout mice were backcrossed into a
C57BL/6 background for at least seven generations.
 
Intravital Microscopy.
 
For intravital microscopy, mice were
anesthetized with an intraperitoneal injection of ketamine hydro-
chloride (100 mg/kg, Ketalar; Parke-Davis) after pretreatment
with xylazine (0.05 mg/kg i.p.) and atropine (0.1 mg/kg i.p.;
Elkins-Sinn). Animals were kept at 37
 
8
 
C with a thermo-con-
trolled heating pad. Some mice were pretreated 2 or 6 h before
surgery with an intrascrotal injection of 0.5 
 
m
 
g murine TNF-
 
a
 
(Genzyme Corp.) in 0.3 ml isotonic saline as described (26). In the
6-h TNF-
 
a 
 
model (30), the intrascrotally injected volume con-
tained 30 U Heparin (Elkins-Sinn). Also, these mice were in-
jected with 100 
 
m
 
g of mAb RB40.34 and 100 
 
m
 
g of mAb 9A9
intraperitoneally before the TNF-
 
a 
 
treatment.
 
Local Catheter. 
 
For local injection of the protease inhibitor
KD-IX-73-4 and the negative control SI into the microcircula-
tion of the cremaster muscle, a heparinized catheter was placed
into the proximal part of the right femoral artery and advanced
towards the branching section of the internal iliac artery from the
common iliac artery, as shown in Fig. 1. The solutions (KD-IX-
73-4 and SI) were injected as a 0.1-ml bolus containing 50 
 
m
 
g
peptide. Upon injection of the bolus into the vasculature of the
cremaster muscle, a brief hemodilution of the blood flowing
through the observed venule indicated passage of the injected
fluid. Centerline velocity and hematocrit returned to normal
shortly after the passage of the bolus through the venule.
 
Cremaster.
 
The cremaster muscle was prepared for intravital
microscopy as described (31) and superfused with thermo-con-
trolled 35
 
8
 
C bicarbonate-buffered saline saturated with 95% N
 
2
 
/
5% CO
 
2
 
 (26). The exposed cremaster microcirculation remained
well perfused. Time 0 was set at the beginning of the cremaster
surgery, which took 
 
z
 
15 min. In the case of TNF-
 
a
 
–pretreated
animals, time 0 was set at the time of scrotal injection with 500 ng
TNF-
 
a 
 
in 0.3 ml saline.
Microscopic observations were made on an Axioskope intra-
vital microscope (Carl Zeiss) with a saline immersion objective
(SW 40/0.75 numerical aperture). Each venule was observed for
90–120 s. Venules with diameters between 25 and 45 
 
m
 
m were
Figure 1. Schematic of local catheter. Stream of the injected fluid
(black arrow) mixes with blood from the arteria iliaca communis (gray ar-
row) into arteria iliaca interna (white arrows) to reach the microcirculation
of the mouse cremaster muscle. 
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observed, and video recordings were made through a CCD cam-
era system (model VE-1000CD; Dage-MTI) on a Panasonic S-VHS
recorder. Microvascular centerline red blood velocity was mea-
sured using a dual photodiode and a digital on-line cross-correla-
tion program (32). Centerline velocities were converted to mean
blood flow velocities by multiplying with an empirical factor of
0.625 (33). Shear rates were determined as 
 
g
 
w
 
 
 
5 
 
2.12 
 
3 
 
8
 
V
 
b
 
/
 
d
 
,
where 
 
g
 
w
 
 is the wall shear rate, 
 
V
 
b
 
 is the mean blood flow veloc-
ity, 
 
d
 
 is the in vivo diameter of the vessel, and 2.12 is a median
empirical correction factor obtained from actual velocity profiles
measured in microvessels in vivo (34).
For continuous blood pressure monitoring and blood sam-
pling, the carotid artery was cannulated with a heparinized PE-10
tubing. Blood samples of 10 
 
m
 
l volume each were taken before
and 10 min after the systemic application of the protease inhibitor
KD-IX-73-4 and SI to analyze systemic leukocyte concentrations
(1:9 dilution with Kimura [11 ml of 5% (wt/wt) toluidine blue,
0.8 ml of 0.03% light green SF yellowish, 0.5 ml of saturated sapo-
nin, and 5 ml of 0.07 M phosphate buffer, pH 6.4; all reagents
obtained from Sigma]). Three different vessels in each cremaster
preparation were selected for observations before and 1–15 min
after the application of the protease inhibitor KD-IX-73-4 or the
negative control SI. All vessels had calculated wall shear rates be-
tween 600 and 800 s
 
2
 
1
 
. Microvessel diameters and individual
rolling leukocyte velocity were measured using a digital image
processing system (32). Freeze-frame advancing was used to ac-
curately monitor the movements of the individual rolling leuko-
cytes. Each rolling leukocyte passing a line perpendicular to the
vessel wall was followed for 0.5–1 s. Rolling velocities for indi-
vidual leukocytes were calculated by dividing the traveled dis-
tance by the tracking time. Critical velocities were calculated for
each vessel (35). The leukocyte rolling flux was determined from
video recordings by counting all visible cells passing through a
plane perpendicular to the vessel axis for 1 min before and 1 min
after the systemic application of the protease inhibitor, starting
1 min after injection.
 
Flow Cytometry.
 
Mice were injected with KD-IX-73-4, or
vehicle alone, and blood was obtained from the subclavian vein at
1 min after the injection. Mouse peripheral blood was stained with
PE-conjugated anti–L-selectin mAb clone (cat. 01265B; PharMin-
gen) or PE-conjugated isotype control mAb (rat IgG2a, cat.
11025A; PharMingen) 2 
 
m
 
l/ml at 4
 
8
 
C for 15 min. After lysis of the
erythrocytes (lysing solution: 0.15 M NH
 
4
 
Cl, 0.01 M NaHCO
 
3
 
,
and 0.001 M disodium EDTA), cells were washed once with
BSA/PBS and fixed in 1% paraformaldehyde/PBS, and 0.5–1 
 
3
 
10
 
4
 
 cells/sample were analyzed by flow cytometry on a FACScan
 
®
 
(Becton Dickinson). The results reported are for granulocytes,
gated by their characteristic forward and side scatter.
 
Statistical Analysis. 
 
Statistical comparisons were carried out
using Kolmogorov-Smirnov two-sample 
 
t
 
 test. NCSS statistical
software (http://www.icw.com/ncss) version 6.0.11 was used for
the statistical analysis. Statistical significance was set at
 
 P 
 
, 
 
0.05
or
 
 P 
 
, 
 
0.01.
Figure 2. Cumulative frequency of velocities of rolling leukocytes in
wild-type mice. Each data point shows the fraction of all rolling leuko-
cytes travelling below the indicated velocity. Open circles, velocities of
rolling leukocytes on endothelium of cremaster muscle venules after acute
exteriorization. Filled circles, velocities of rolling leukocytes after systemic
application of 150 mg protease inhibitor, KD-IX-73-4 (significantly
lower, P , 0.01). Data obtained between 1 and 8 min after intravenous
injection of the protease inhibitor. Each data point stands for the mean of
15 cells, obtained from 5 animals.
Figure 3. Composite of five superimposed video frames before and af-
ter application of KD-IX-73-4 from the same postcapillary venule of a
wild-type mouse. Time elapsed between the first and last frame in each
picture is 0.8 s. The distance traveled by a leukocyte in each panel illus-
trates the regulatory function of L-selectin shedding on leukocyte rolling
velocity. Bar, 50 mm. 
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Results
 
Inhibition of L-selectin Shedding Lowers Leukocyte Rolling
Velocity under Physiologic Conditions In Vivo.
 
Fig. 2 shows
the results of inhibition of L-selectin shedding in wild-type
mice. Velocities of 750 rolling leukocytes in 15 vessels of
5 wild-type mice were obtained before and after the appli-
cation of KD-IX-73-4. Observations were made 1–8 min
after the injection of the protease inhibitor and within the
first 1 h after starting the cremaster preparation. The mean
velocity of all observed cells before the inhibition of L-selec-
tin shedding was 59 
 
6 
 
5.6 
 
m
 
m/s and after the inhibition
was 39 
 
6 
 
3.6 
 
m
 
m/s, which represents a reduction of the
mean velocity by 33 
 
6 
 
2%. As an example, Fig. 3 shows a
composite photomicrograph illustrating the change in roll-
ing velocity in one representative vessel.
The related hydroxamic acid–based substance (SI) did not
show any significant effect on the velocities of the rolling
leukocytes. Interestingly, after the use of 150 
 
m
 
g SI (1 
 
m
 
g/
 
m
 
l), the subsequent injection of 150 
 
m
 
g KD-IX-73-4 did not
show any change in the velocity of rolling leukocytes, sug-
gesting a possible competitive mechanism of interaction be-
tween the two hydroxamic acid–based substances and the
L-selectin cleaving protease. Fig. 4 shows the results of the SI
application followed by KD-IX-73-4 in wild-type mice.
To determine the duration of the effect of the protease
inhibitor in vivo, single venule recordings were made in
two wild-type animals for 15–20 min after the application
of KD-IX-73-4. Rolling velocities of 10 cells were ob-
tained in 1-min steps after the injection of 150 
 
m
 
g KD-IX-
73-4. Within the first 1 min after the injection of 150 
 
m
 
g
KD-IX-73-4, the reduction of rolling velocity could be
observed and persisted for 
 
z
 
9–10 min, after which the
rolling velocity returned to control levels (Fig. 5).
Figure 4. Cumulative frequency of velocities of
rolling leukocytes in wild-type mice before and after
application of SI and KD-IX-73-4, 150 mg. Open
circles, after acute exteriorization; open triangles,
after SI application; filled circles, after SI followed
by KD-IX-73-4 application. Six measurements in
two animals per data point. Velocities of 50 rolling
cells in each vessel obtained before and after the in-
jection of the control substance SI and after the
subsequent injection of the protease inhibitor KD-
IX-73-4 (no significant velocity difference).
Figure 5. Leukocyte rolling velocities from sin-
gle vessel recordings after application of 150 mg
protease inhibitor KD-IX-73-4. Rolling velocities
of 10 cells per vessel obtained at 1-min intervals to
follow the change of the mean velocity of these
cells over time. Each data point is the mean of 20
rolling leukocytes from 2 wild-type mice. 
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To assess whether the injected dose of KD-IX-73-4 re-
sulted in complete inhibition of L-selectin shedding in
vivo, we investigated the expression of L-selectin on neu-
trophils in peripheral blood by flow cytometry (Fig. 6). All
neutrophils in peripheral blood of untreated mice expressed
L-selectin, which was almost entirely downregulated after
PMA activation. In contrast, PMNs obtained from mice
1 min after KD-IX-73-4 injection did not shed L-selectin
in response to PMA activation. The inhibitory effect of
KD-IX-73-4 in vivo was no longer detectable at 15 min
after the injection. SI, the peptide used as a control, did not
show any inhibitory effect on L-selectin shedding after
PMA activation of the cells. Taken together, these data
show that KD-IX-73-4 transiently inhibits L-selectin shed-
ding in vivo. The time course of this inhibitory effect paral-
lels the time course of reduction of rolling velocity by
KD-IX-73-4.
Systemic application of 150–300 
 
m
 
g KD-IX-73-4 did
not cause an alteration of the systemic blood pressure,
which remained between 80 and 95 mmHg throughout
the experiments. Likewise, centerline velocities and diameters
(and consequently the shear rates) of the observed venules
were not affected by the systemic injections of KD-IX-73-4
or SI. Also, systemic white blood cell counts remained un-
changed after systemic injection of KD-IX-73-4 (Table I).
To determine whether the injected amount of KD-IX-
73-4 (150 
 
m
 
g) in vivo was sufficient to cause maximal re-
duction of velocity, subsequent injections of KD-IX-73-4
(150–300 
 
m
 
g) were made in two wild-type animals to achieve
an accumulation of the protease inhibitor in plasma. Such
injections did not cause a further shift of velocities of the
rolling cells compared with the cell rolling velocities after
the first injection of 150 
 
m
 
g KD-IX-73-4 (data not shown).
Therefore, an injection of 150 
 
m
 
g KD-IX-73-4 into a
mouse produced complete inhibition of L-selectin shed-
ding and maximal reduction of rolling velocity in vivo.
As another parameter relevant for leukocyte trafficking,
the flux of rolling leukocytes (number of rolling cells pass-
ing per unit of time) was measured in eight vessels of wild-
type mice. Inhibition of L-selectin shedding caused a sig-
nificant 22% increase of rolling flux compared with the
mean of the rolling flux of the same vessels before the KD-IX-
73-4 treatment (118 cells/min). This finding suggests that
inhibition of L-selectin shedding not only reduces the ve-
locity of rolling leukocytes, but also aids in promoting leu-
kocyte capture from the free stream and/or stabilizes their
rolling along the venular tree. Furthermore, the number of
firmly adherent leukocytes was significantly increased after
inhibition of L-selectin shedding in mice treated with
TNF-
 
a 
 
for 6 h (data not shown). In this model, rolling is
primarily L-selectin dependent (30). Concomitant with in-
creased adhesion, inhibition of L-selectin shedding also in-
creased the number of transmigrating cells, apparent by the
characteristic change of shape during their transendothelial
passage (data not shown). This suggests that, beyond its
prominent and immediate effect on the velocity of rolling
leukocytes, L-selectin shedding significantly impacts leuko-
cyte recruitment.
To investigate whether the effect of KD-IX-73-4 on the
leukocyte velocities in vivo is specific to the inhibition of
L-selectin shedding or whether other variables contribute
to the shift of velocities, experiments with L-selectin–defi-
cient mice were made. Fig. 7 shows leukocyte rolling ve-
locities obtained in L-selectin–deficient mice before and af-
Figure 6. Flow cytometry of mouse PMNs for ex-
pression of L-selectin with PE-conjugated mAb,
Mel-14.  a, PMNs, no mAb; b, L-selectin expression
without activation; c, L-selectin expression after acti-
vation with PMA (100 ng/ml, 20 min at 378C); d, 1
min after KD-IX-73-4 injection (150 mg); e, 1 min
after KD-IX-73-4 injection and subsequent PMA
activation; f, 15 min after KD-IX-73-4 injection and subsequent PMA
activation; and g, 1 min after SI injection and subsequent PMA activation.
Table I. Leukocyte Counts and Hemodynamic Parameters, Mean 6 SEM
White blood cell counts Velocity Diameter Wall shear rate, g
3106 cells/ml mm/s mms 21
Before KD-IX-73-4 4.3 6 0.4 2.8 6 0.3 39 6 5 758 6 67
After KD-IX-73-4 4.2 6 0.3 2.7 6 0.3 40 6 4 770 6 58
After SI 4.4 6 0.3 2.6 6 0.2 46 6 3 610 6 32944 L-selectin Shedding Modulates Leukocyte Rolling Velocity
ter systemic application of KD-IX-73-4. There was no
significant change of the mean rolling velocities measured
after application of KD-IX-73-4 (37 6 1.4 mm/s before
and 38.2 6 1.5 mm/s after the inhibition; 100 cells from
2 animals). The absence of the reduction of velocity in
L-selectin–deficient mice shows that inhibition of L-selec-
tin shedding with KD-IX-73-4 does not alter the rolling
velocity of leukocytes unless L-selectin is expressed. Flux
also remained unchanged after injection of KD-IX-73-4 in
L-selectin–deficient mice (data not shown).
The systemic application of the protease inhibitor into
the jugular vein is likely to produce a homogenous serum
concentration of the inhibitor throughout the vascular sys-
tem. However, in order to be able to make a statement
about the onset of the effect of KD-IX-73-4 on rolling ve-
locity, it was necessary to observe rolling leukocytes from
the moment of their first contact with the inhibitor. For
this purpose, the protease inhibitor was injected as a small
bolus (50 mg/0.1 ml) through a local catheter (Fig. 1) into
the microcirculation of cremaster muscle. With the passage
of the solution through the cremaster vasculature, the in-
hibitor washed over rolling leukocytes in the cremaster
venules and might inhibit L-selectin shedding in these cells
within the field of view. A brief hemodilution effect caused
by injection of the bolus furnished evidence for the passage
of the solution through the observed venules. Within the
first 5 s after the passage of the bolus, velocities of 25 rolling
leukocytes/venule were obtained. The mean velocity of 50
rolling leukocytes from 2 animals before contact with the
protease inhibitor was 40.2 6 3.1 mm/s, which was low-
ered to 29.9 6 2.7 mm/s immediately after the injection of
KD-IX-73-4. This equals a 26% reduction of leukocyte
rolling velocity.
To explore the role of L-selectin shedding during cyto-
kine-induced inflammation, we used intrascrotal injection
of TNF-a 3 h before the observation period, as described
previously (6). Treatment of wild-type mice with intra-
scrotal injections of 0.5 mg TNF-a 2 h before the experi-
ments causes the expression of E-selectin and increased
expression of P-selectin on the endothelial cells (36). Pres-
ence of E-selectin on the endothelium of the cremaster
venules lowers the mean leukocyte rolling velocity by al-
most one order of magnitude to under 5 mm/s (37). Fig. 8
A shows results of inhibition of L-selectin shedding with
KD-IX-73-4 in TNF-a–treated wild-type mice. The
mean velocity of 300 rolling leukocytes (4.5 mm/s) before
application of the protease inhibitor did not change signi-
ficantly compared with the mean of 300 rolling leukocytes
(4.1 mm/s) obtained between 1 and 6 min after the applica-
tion of 150 mg KD-IX-73-4.
We hypothesized that E-selectin–mediated leukocyte
rolling proceeded at such low velocities that inhibition of
L-selectin shedding did not influence the actual velocity
because the low off-rate of E-selectin (38) would deter-
mine and dominate the rolling velocity, no matter whether
L-selectin was being shed or not. Previous studies had shown
that rolling velocities were significantly higher in E-selectin–
deficient mice treated with TNF-a than in wild-type mice
(37). To explore the reason for the apparent absence of an
effect of inhibiting L-selectin shedding in TNF-a–treated
mice, we used TNF-a–treated E-selectin–deficient mice. In
these mice, mean rolling velocity was 24 mm/s and was re-
duced to 17 mm/s after treatment with KD-IX-73-4 (a 29%
reduction of mean rolling velocity; Fig. 8 B).
Discussion
Although proteolytic cleavage of L-selectin from the sur-
face of leukocytes was described as early as 1989 (11, 12),
the physiologic relevance of L-selectin shedding in vivo has
remained unclear and the subject of controversial specula-
tions. The results of this study establish L-selectin shedding
Figure 7. Cumulative frequency of velocities of
rolling leukocytes in L-selectin–deficient mice be-
fore and after application of KD-IX-73-4. Open
circles, after acute exteriorization; filled circles, after
KD-IX-73-4 application (150 mg). No reduction
of rolling velocity in L-selectin–deficient mice.
Mean velocity of 100 rolling cells, obtained from 2
male wild-type animals, is 37 6 1.4 mm/s before
the inhibition of L-selectin shedding, and 38.2 6
1.5 mm/s after the injection of KD-IX-73-4 (not
significant).945 Hafezi-Moghadam and Ley
as a novel parameter, in addition to adhesion molecule ex-
pression and hemodynamic forces, relevant for regulation
of leukocytes rolling. Continuous L-selectin shedding ap-
pears necessary for physiologic leukocyte rolling at typical
velocities. Though Walcheck et al. have noted that inhibi-
tion of L-selectin shedding lowers the rolling velocity of
isolated neutrophils on immobilized MECA-79 antigen
(23), the results of other in vitro experiments using cul-
tured endothelial cells seemed to contradict their conclu-
sion (24). In experiments with TNF-a–treated HUVECs, a
role for L-selectin shedding in neutrophil attachment, roll-
ing, or transmigration could not be shown. Our results in
untreated and TNF-a–treated wild-type mice can explain
this discrepancy and establish the role of L-selectin shed-
ding for leukocyte trafficking.
When E-selectin is expressed on endothelial cells, inhibi-
tion of L-selectin shedding has no effect on leukocyte roll-
ing velocity. However, when E-selectin is not expressed,
either in wild-type mice not treated with an inflammatory
cytokine, or in E-selectin–deficient mice, the modulatory
role of L-selectin shedding is evident. In TNF-a–treated
cultured HUVECs (24), E-selectin is likely to be expressed.
This would explain why Allport et al. (24) did not find a ve-
locity difference between human neutrophils with or with-
out incubation with a zinc-dependent metalloproteinase
inhibitor (Ro 31-9790). In the experiment of Walcheck et
al. (23), E-selectin is not present, because a purified L-selec-
tin ligand (MECA-79) is used as the sole adhesive substrate.
We investigated the effect of inhibiting L-selectin on roll-
ing in vivo both in the presence and absence of E-selectin.
In the absence of E-selectin, inhibition of L-selectin shed-
ding causes a significant decrease of rolling velocity (as in ref-
erence 23), which is not detectable when E-selectin is in-
volved in mediating leukocyte rolling (as in reference 24).
As presented in Fig. 2, a shift towards lower leukocyte
rolling velocities can be seen with the inhibition of L-selec-
tin shedding in wild-type mice without intentional induc-
tion of inflammation. The amount of protease inhibitor
used in these animals provided a maximum inhibition of
L-selectin shedding, since further injections of KD-IX-73-4
did not lower the rolling velocity of the cells further. The
shift of velocity in these animals shows that normal leukocyte
rolling requires continuous shedding of L-selectin. Consis-
tent with this, Palecanda et al. detected soluble L-selectin in
the plasma of healthy adults, whose peripheral blood leuko-
cytes did not demonstrate any obvious signs of activation
(39), and Schleiffenbaum et al. found high physiologic lev-
els of soluble L-selectin in the serum of healthy volunteers
(16). Since no soluble or secreted splice variants of L-selec-
tin are known, we hypothesize that continuous L-selectin
shedding during physiologic leukocyte rolling is a likely
source for soluble L-selectin in the plasma of healthy indi-
viduals.
The fact that no change in the rolling velocity can be mea-
sured with the protease inhibitor KD-IX-73-4 in L-selectin–
deficient mice shows that the observed shift of velocities in
wild-type mice was specifically and exclusively caused by
the inhibition of L-selectin shedding. Other molecules such
as P- or E-selectin, which also mediate leukocyte rolling,
do not contribute to the shift of velocity caused by the ap-
plication of KD-IX-73-4.
As a negative control, we used the hydroxamic acid–
based substance (SI), which is structurally closely related to
the protease inhibitor KD-IX-73-4 but does not inhibit
L-selectin shedding as shown by flow cytometry. Interest-
ingly, after the use of SI, subsequent injections of KD-IX-
73-4 did not show a shift of velocity. Therefore, SI may in-
teract with the protease responsible for L-selectin shedding
at the same binding site as KD-IX-73-4, thus competing
with KD-IX-73-4 binding. PMNs from KD-IX-73-4–
treated wild-type mice do not shed L-selectin in response
to PMA activation. However, the inhibitory effect of KD-IX-
73-4 in vivo is not permanent, as PMNs obtained 15 min
Figure 8. (A) Cumulative frequency of velocities of rolling leukocytes
in TNF-a–treated wild-type mice (3 h before the injection of the pro-
tease inhibitor). Open circles, before; filled circles, after KD-IX-73-4 in-
jection (150 mg). Mean value of six measurements from two animals per
data point. (B) Cumulative frequency of velocities of rolling leukocytes in
TNF-a–treated E-selectin–deficient mice. Mean value of four measure-
ments from two animals per data point.946 L-selectin Shedding Modulates Leukocyte Rolling Velocity
after KD-IX-73-4 treatment responded to PMA activation
by shedding L-selectin. This parallels our observations from
the functional assay (Fig. 5) that the shift of velocity lasts for
z10 min after one injection. The inhibition of L-selectin
shedding in vivo and the velocity shift in the functional
assay can both be observed after the injection of the pro-
tease inhibitor KD-IX-73-4. These data are consistent with
a causal relationship between the injection of KD-IX-73-4,
the inhibition of the L-selectin shedding, and the shift of
rolling velocity.
The current findings show that proteolytic cleavage of
L-selectin shedding is relevant for physiologic leukocyte
rolling. Since enzymatic processes often require metabolic
energy, it may be worthwhile exploring whether L-selec-
tin–mediated leukocyte rolling is modulated by cell metab-
olism or whether it is as independent of cell metabolism as
formerly believed (40, 41). Furthermore, in light of the
present study, a revision of the calculated dissociation rate
of L-selectin appears necessary, which was made with the
assumption that during stable rolling the average number of
bonds that form and break will be equal (9). This assump-
tion may prove erroneous, since inhibition of L-selectin
shedding decreases rolling velocity. Therefore, we believe
that the 7.5–11.5-fold faster L-selectin–mediated rolling
does not necessarily require a 7–10-fold more rapid bond
dissociation, as proposed by Alon et al. (9). Rather, contin-
uous cleavage of L-selectin and breakage of bonds are likely
to occur at the same time and thus cause short duration of
L-selectin–mediated tethering events.
In conclusion, inhibition of L-selectin shedding decreases
the leukocyte rolling velocity and increases the leukocyte
rolling flux in vivo. A decreased rolling velocity increases
the transit time of rolling leukocytes. Leukocyte transit
times have recently been shown to be an important deter-
minant of leukocyte recruitment in vivo (42). Modulation
of L-selectin shedding is a novel and influential parameter
in the leukocyte trafficking by virtue of its regulatory func-
tion on rolling velocity, rolling flux, and transit time of
leukocytes.
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